All News

Standing Up to Cancer Means Not Letting It Steal My Joy

August 27th 2025, 5:00pm

Article

Standing up to cancer means focusing on the blessings, reveling in good news, and living life to its fullest every day.

PDS0101 Plus Keytruda Elicits Survival Response in Head and Neck Cancer

August 27th 2025, 4:00pm

Article

In HPV15-positive first-line recurrent and/or metastatic head and neck cancer, PDS0101 and Keytruda elicited median overall survival more than three years.

What Does Gastrointestinal Cancer Mean?

August 27th 2025, 3:00pm

Article

Here is a primer on what patients who have received a diagnosis of gastrointestinal cancer need to know.

AI Tools Speed Prostate Cancer Decisions With Faster Results

August 27th 2025, 1:00pm

Video

FDA-authorized AI tools have the potential to help patients with prostate cancer get clearer answers instead of waiting weeks for genomic test results.

How Can We Stand Up to Cancer as Patients?

August 26th 2025, 9:00pm

Article

I share practical strategies for living well with cancer, from research and self-care to support, creativity, and wise giving.

How Risk Status Can Affect Breast Cancer Treatment Decisions

August 26th 2025, 8:00pm

Video

Dr. William Audeh explains how treatment decisions for breast cancer can be informed by a patient’s ultra-low, low or high genomic risk status.

Non-Drug Therapies and Support Improve Cancer Care Outcomes

August 26th 2025, 7:00pm

Article

Non-drug therapies, counseling and telehealth improved pain, mood and communication in cancer care, though older adults and minorities remain underrepresented.

One Stitch at a Time: Crocheting and Coping with a Cancer Diagnosis

August 26th 2025, 5:00pm

Article

After an blood cancer diagnosis and stem cell transplant, I found purpose in crochet, turning fear into creativity and connection one stitch at a time.

Rina-S Earns Breakthrough Designation in Advanced Endometrial Cancer

August 26th 2025, 4:00pm

Article

Rina-S earned breakthrough therapy designation for patients with advanced endometrial cancer whose disease has worsened after platinum-based chemotherapy.

FDA Grants Breakthrough Device Status to MRD Test in Colorectal Cancer

August 26th 2025, 3:00pm

Article

The FDA granted breakthrough device designation to Quest Diagnostics’ Haystack MRD test for patients with stage 2 colorectal cancer after surgery.